Latest information on COVID-19
Support teaching, research, and patient care.
Shuchi Anand M.D. M.S. is Director of the Center for Tubulointerstitial Kidney Disease at Stanford University (http://stan.md/tikidney). She received her Medical Degree from Washington University School of Medicine in St. Louis, and completed her internal medicine training at Brigham and Women's Hospital (Partners Healthcare, Harvard Medical School) in Boston. She completed her Masters in Clinical Epidemiology and nephrology fellowship at Stanford University School of Medicine. Dr. Anand is engaged in clinical research aimed at advancing the care of patients with kidney disease living in low-resource settings using practical tools. She has active projects in collaboration with University of Utah promote exercise programming for underserved populations, with Center for Chronic Disease Control in India to study risk factors for kidney disease in South Asians, and with Kandy Hospital Sri Lanka to investigate chronic kidney disease of unknown etiology affecting agricultural communities. During the COVID19 pandemic Dr Anand also participated in partnership to elucidate sero-epidemiology, vaccine acceptance and response to vaccination among patients on dialysis. She is part of two NIH consortia focused on improving the health of underserved populations.
Working with collaborators at Kandy Teaching Hospital and University of Peradeniya to understand clinical features and epidemiology of Chronic Kidney Disease of Unknown Etiology
Kandy, Sri Lanka
Working with CCDC in New Delhi India to identify prevalence, incidence and risk factors for chronic kidney disease in a population based cohort
New Delhi, India
Supporting peritoneal dialysis
Dr Anand is interested in improving care for patients with kidney disease living in low-resource settings and using practical tools. She has active projects in India and Sri Lanka. She is also involved with the Exercise is Medicine initiative, with an active pilot clinical trial in adapting the intervention for patients with advanced kidney disease.
Exercise is Medicine for Patients With CKD
The investigators plan to integrate and tailor the existing Exercise is Medicine framework,
an evidence-based multi-level intervention program developed by the American Society of
Sports Medicine, for the care of patients with advanced chronic kidney disease. In this pilot
randomized control trial, investigators will compare the effects and feasibility of two
intervention arms designed to start and maintain physical activity in this high-risk
population (Group 1: physical activity assessment, brief counseling session + physical
activity wearable versus Group 2: Group 1 intervention components + referral to a free,
community-based, EIM practitioner led group exercise program).
Stanford is currently not accepting patients for this trial.
For more information, please contact SPECTRUM, .
View full details